Jeffrey Zekauskas Maintained (AXTA) at Buy with Increased Target to $33 on, Apr 26th, 2018
Jeffrey has made no other calls on AXTA in the last 4 months.
There are 3 other peers that have a rating on AXTA. Out of the 3 peers that are also analyzing AXTA, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Aleksey Yefremov of "Nomura" Maintained at Hold with Increased Target to $31 on, Thursday, February 8th, 2018
These are the ratings of the 2 analyists that currently disagree with Jeffrey
- Chris Parkinson of "Credit Suisse" Maintained at Buy with Increased Target to $35 on, Wednesday, February 7th, 2018
- Steve Byrne of "B of A Securities" Initiated at Sell and Held Target at $28 on, Tuesday, January 16th, 2018
on: Thu, Apr 12th 2018
by: WOPRAI
Kristine Liwag Maintained (TDG) at Hold with Increased Target to $321 on, Apr 12th, 2018
on: Wed, Mar 28th 2018
by: WOPRAI
John McNulty Initiated (AXTA) at Hold and Held Target at $33 on, Mar 28th, 2018
on: Thu, Feb 08th 2018
by: WOPRAI
Aleksey Yefremov Maintained (AXTA) at Hold with Increased Target to $31 on, Feb 8th, 2018
on: Wed, Feb 07th 2018
by: WOPRAI
Chris Parkinson Maintained (AXTA) at Buy with Increased Target to $35 on, Feb 7th, 2018
on: Tue, Jan 16th 2018
by: WOPRAI
Steve Byrne Initiated (AXTA) at Sell and Held Target at $28 on, Jan 16th, 2018
on: Mon, Nov 13th 2017
by: WOPRAI
Laurence Alexander Maintained (AXTA) at Strong Buy with Increased Target to $38 on, Nov 13th, 2017
on: Mon, Nov 06th 2017
by: WOPRAI
Chris Parkinson Maintained (AXTA) at Buy with Increased Target to $37 on, Nov 6th, 2017
on: Tue, Oct 10th 2017
by: WOPRAI
PJ Juvekar Downgraded (AXTA) to Strong Sell on, Oct 10th, 2017
on: Tue, Oct 10th 2017
by: WOPRAI
Aleksey Yefremov Maintained (AXTA) at Hold with Decreased Target to $28 on, Oct 10th, 2017
on: Fri, Aug 11th 2017
by: WOPRAI
on: Tue, Feb 16th 2016
by: WOPRAI
Laurence Alexander Upgraded (AXTA) to Strong Buy on, Feb 16th, 2016
on: Tue, Apr 15th 2014
by: WOPRAI
Jeffrey Bernstein Maintained (CAKE) at Hold with Increased Target to $54 on, Apr 15th, 2014